×

Methods for treating conditions associated with lectin-dependent complement activation

  • US 20060018896A1
  • Filed: 06/09/2005
  • Published: 01/26/2006
  • Est. Priority Date: 06/10/2004
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of inhibiting lectin-dependent complement activation in a subject in need thereof, comprising administering to the subject an amount of a MAp19 inhibitory agent effective to inhibit lectin-dependent complement activation.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×